Possibilities of Hyperinflammation Correction in COVID-19

Possibilities of Hyperinflammation Correction in COVID-19

Objective. To evaluate the effect of sodium meglumine succinate on the severity of the systemic inflammatory response syndrome when used in complex therapy in patients with severe COVID-19.Material and Methods. The clinical and laboratory data of 12 patients with the diagnosis «Novel coronavirus inf...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. S. Simutis, G. A. Boyarinov, M. Yu. Yuriev, D. S. Petrovsky, A. L. Kovalenko, S. A. Parfenov
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2021-06-01
Series:	Антибиотики и Химиотерапия
Subjects:	systemic inflammatory response syndrome sirs cytokine storm sars-cov-2 covid-19 meglumine sodium succinate
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/804
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Meglumine Sodium Succinate to Correct COVID-19-Associated Coagulopathy: the Feasibility Study
by: I. S. Simutis, et al.
Published: (2021-07-01)

Preliminary Results of Adding Meglumine Sodium Succinate to the Treatment of Patients with Moderate to Severe Acute Pancreatitis
by: A. L. Kovalenko, et al.
Published: (2021-02-01)

Substantiation of the Combined Use of Negative Pressure Therapy and Meglumine Sodium Succinate in the Treatment of Wounds of Various Etiologies
by: M. V. Varganov, et al.
Published: (2023-07-01)

Effect of Succinate Crystalloid Solution on Hemostasis in Children with Severe Community-acquired Pneumonia
by: Vladimir V. Lazarev, et al.
Published: (2024-10-01)

Meglumine Sodium Succinate in Diabetic Ketoacidosis
by: M. I. Neimark, et al.
Published: (2023-06-01)

Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19
by: Z. A. Kalmykova, et al.
Published: (2020-08-01)

MECHANISMS OF CYTOKINE STORM DEVELOPMENT IN COVID-19 AND NEW POTENTIAL TARGETS OF PHARMACOTHERAPY
by: V. I. Petrov, et al.
Published: (2021-05-01)

Effect of Xenon on Proinflammatory Activation and Apoptosis of Human Neutrophils Under Ex Vivo Conditions
by: O. A. Grebenchikov, et al.
Published: (2021-11-01)

Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors
by: Huan Han, et al.
Published: (2020-01-01)

Thrombectomy in patients with basilar artery thrombosis
by: G. R. Ramazanov, et al.
Published: (2021-11-01)

Dexamethasone as a Treatment of COVID-19
by: Abdullah Alkattan, et al.
Published: (2021-01-01)

Ways to optimize infusion therapy for diabetic ketoacidosis
by: M. I. Neimark, et al.
Published: (2025-04-01)

Mitigation of hepatic and gastric impairments induced by flunixin meglumine through co-administration with alpha lipoic acid in male rats
by: Zeynab Kh. El-Maddawy, et al.
Published: (2025-05-01)

EFFICACY AND SAFETY OF ORIGINAL DRUG BASED ON HEXAPEPTIDE SUCCINATE IN COMPLEX COVID-19 THERAPY IN ADULTS HOSPITALIZED PATIENTS
by: L. A. Balykova, et al.
Published: (2023-02-01)

Immunopathogenesis of Acute Pancreatitis
by: G. V. Bulava
Published: (2022-10-01)

A perfect storm: the deadly intersection of sickle cell disease and COVID-19
by: Arturo José Martí-Carvajal, et al.
Published: (2025-08-01)

Age-related immune response disparities between adults and children with severe COVID-19: a case–control study in China
by: Hongliang Chen, et al.
Published: (2025-02-01)

Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
by: Basil Mohammed Alomair, et al.
Published: (2023-04-01)

Breakthrough Infection and Death after COVID-19 Vaccination: A Physics Perspective
by: Seyed Ali Reza Mortazavi, et al.
Published: (2025-06-01)

Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
by: Cody J. Bills, et al.
Published: (2023-12-01)

Fetal systemic inflammatory response syndrome, thromboinflammation and neonatal septic shock: pathogenesis, diagnostics and treatment
by: V. O. Bitsadze, et al.
Published: (2025-05-01)

A retrospective evaluation of COVID-19 patients treated with Tocilizumab: who should be treated?
by: Semiha Çelik Ekinci, et al.
Published: (2021-12-01)

The Eﬀect of Hemoadsorption with CytoSorb on Severe COVID-19 Complications
by: A. S. Rybalko, et al.
Published: (2024-09-01)

Development and Validation of the CARRA-VID Prognostic Score: C Reactive Protein to Albumin Ratio, Red Blood Cell Distribution Width and Age-Based Score for Prognostication of Hospitalized COVID-19 Patients
by: Marko Lucijanic, et al.
Published: (2025-04-01)

Neuropilin‐1 as a Neuroinflammatory Entry Factor for SARS‐CoV‐2 Is Attenuated in Vaccinated COVID‐19 Patients: A Case–Control Study
by: Faezeh Hosseini, et al.
Published: (2025-04-01)

Insulin-Like Growth Factor Binding Protein, Acid-Labile Subunit Serum Level During the Acute and Convalescent Stage of SARS-CoV-2 Infection Depicted in a Longitudinal Study of 72 Patients During the First Wave of Pandemic
by: Gad H, et al.
Published: (2025-06-01)

Immunological criteria for the diagnosis of multisystem inflammatory syndrome associated with MERS-COV-2 and infectious diseases with sepsis in children
by: Yu. E. Konstantinovа, et al.
Published: (2024-12-01)

Incidence and risk factors of new clinical disorders in patients with COVID-19 hyperinflammatory syndrome
by: Kevin E. Duong, et al.
Published: (2025-06-01)

Stress, lipid profile and inflammatory responses to flunixin meglumine administration in surgical and non-surgical castration in donkeys
by: Hamidreza Alipour-Khairkhah, et al.
Published: (2025-03-01)

Immune correction in patients with sepsis (literature review)
by: A. V. Stepanov, et al.
Published: (2024-04-01)

A comprehensive review and meta-analysis of the relationships between interleukin-7 levels and COVID-19 severity
by: Michal MATUSZEWSKI, et al.
Published: (2023-03-01)

Cytokine Storm in the Novel Coronavirus Infection and Methods of its Correction
by: A. V. Ershov, et al.
Published: (2021-02-01)

Multisystem inflammatory syndrome in children and Kawasaki disease
by: Ancuta Lupu, et al.
Published: (2025-04-01)

IMMUN RESPONSES IN COVID-19
by: Bülent Çakal
Published: (2021-04-01)

Retrospective Analysis of the Characteristics of the Post-COVID Period in Patients with Type 2 Diabetes, Infected During Different Variant-Associated Periods of COVID-19
by: S. A. Altynbekova, et al.
Published: (2024-11-01)

Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID‐19 in type 2 diabetes
by: Fawaz Alzaid, et al.
Published: (2020-09-01)

Clinical case of hemophagocytic lymphohistiocytosis: rare or undiagnosed syndrome?
by: O. B. Yaremenko, et al.
Published: (2023-03-01)

CD147-high classical monocytes: a cellular biomarker for COVID-19 disease severity and treatment response
by: Teruaki Murakami, et al.
Published: (2025-04-01)

Determination of embryotoxic and teratogenic effects of flunixin meglumine given early stage in ovo
by: Murat Öznurlu, et al.

IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6
by: E. L. Nasonov
Published: (2020-06-01)